NASDAQ:RAIN

Rain Therapeutics Stock Forecast

etoro logo Buy RAIN
*Your capital is at risk
$1.80
+0.250 (+16.13%)
At Close: Jul 20, 2026
AI Analysis AI Analysis of RAIN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RAIN to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Volatile ride for Rain Therapeutics Inc. stock price on Monday moving between $1.55 and $1.82
(Updated on Jul 20, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 30, 2026 Loss -13.04%

The Rain Therapeutics Inc. stock price gained 16.13% on the last trading day (Monday, 20th Jul 2026), rising from $1.55 to $1.80. During the last trading day the stock fluctuated 16.99% from a day low at $1.55 to a day high of $1.82. The price has fallen in 6 of the last 10 days and is down by -7.69% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 thousand more shares were traded than the day before. In total, 14 thousand shares were bought and sold for approximately $24.82 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.08% during the next 3 months and, with a 90% probability hold a price between $0.96 and $2.07 at the end of this 3-month period.

RAIN Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, July 17, 2026, and so far it has risen 16.13%. Further rise is indicated until a new top pivot has been found. Rain Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Rain Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.01. On a fall, the stock will find some support from the short-term average at $1.68. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Rain Therapeutics Inc. stock

Rain Therapeutics Inc. finds support from accumulated volume at $1.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.264 between high and low, or 16.99%. For the last week, the stock has had daily average volatility of 12.92%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RAIN) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Rain Therapeutics Inc. to open at $1.72, and during the day (based on 14 day Average True Range), to move between $1.68 and $1.92, which gives a possible trading interval of +/-$0.239 (+/-14.21%) up or down from last closing price. If Rain Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 14.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.74 (3.34%) than the resistance at $2.02 (12.22%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Rain Therapeutics Inc. stock A Buy?

Rain Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.321 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 21, 2026 - $1.72 ( 4.20%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RAIN Performance

Trading levels for RAIN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.99 10.47%
R2 1.89 4.87%
R1 1.83 1.40%
Price 1.80
S1 1.62 -9.81%
S2 1.56 -13.27%
S3 1.46 -18.87%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.07 15.00%
R2 2.06 14.44%
R1 2.02 12.22%
Price 1.80
S1 1.74 -3.34%
S2 1.58 -12.22%
S3 1.46 -18.89%

FAQ

What is the symbol for Rain Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Rain Therapeutics Inc. is RAIN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rain Therapeutics Inc. Stock?
Rain Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Rain Therapeutics Inc. Stock?
Rain Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rain Therapeutics Inc. Stock.

What's the current price of Rain Therapeutics Inc. Stock?
As of the end of day on the Jul 20, 2026, the price of an Rain Therapeutics Inc. (RAIN) share was $1.80.

What is the 52-week high and low for Rain Therapeutics Inc. Stock?
The 52-week high for Rain Therapeutics Inc. Stock is $8.50 and the 52-week low is $1.26.

What is the market capitalization of Rain Therapeutics Inc. Stock?
As of the Jul 20, 2026, the market capitalization of Rain Therapeutics Inc. is 14.721M.
Click to get the best stock tips daily for free!
ABOUT RAIN THERAPEUTICS INC.
Rain Therapeutics
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II clinical trial for solid tumors, and Phase II clinica...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
0.578% Jul 13
SRPT
$17.02
1.18% Jun 29
JLL
$299.78
10.30% Jun 24
NMRK
$15.02
3.86% Jun 24
CAG
$13.43
6.29% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE